Growth Metrics

Soleno Therapeutics (SLNO) Return on Assets (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Return on Assets for 8 consecutive years, with 0.04% as the latest value for Q4 2025.

  • For Q4 2025, Return on Assets changed N/A year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, changed N/A, while the annual FY2018 figure was 0.04%, 12.0% up from the prior year.
  • Return on Assets hit 0.04% in Q4 2025 for Soleno Therapeutics, up from 0.07% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.04% in Q4 2025 and bottomed at 0.37% in Q1 2025.